Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease. (Q51629961)

8 April 2018

title

Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease. (English)

1 reference

8 April 2018

1 reference

myocardial infarction

1 reference

Martin J Holzmann

1

1 reference

8 April 2018

Ingmar Jungner

2

1 reference

8 April 2018

Göran Walldius

3

1 reference

8 April 2018

Torbjörn Ivert

4

1 reference

8 April 2018

Tobias Nordqvist

5

1 reference

8 April 2018

Jan Ostergren

6

1 reference

8 April 2018

Niklas Hammar

7

1 reference

8 April 2018

language of work or name

English

0 references

publication date

30 November 2010

1 reference

8 April 2018

published in

Annals of Medicine

1 reference

8 April 2018

volume

44

1 reference

8 April 2018

issue

3

1 reference

8 April 2018

page(s)

262-270

1 reference

8 April 2018

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Mechanisms of dyslipidemia of chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Prevalence of chronic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532153

10.3109/07853890.2010.532153

21 January 2018

Identifiers

DOI

1 reference

8 April 2018

1 reference

8 April 2018